Although EphA2 is implicated in tumor growth and metastasis of many types of solid cancers through ligand-independent signaling [33,34], it can also suppress cell growth via ligand-dependent signaling through ephrin-A1, its primary binding partner [31,35,36]. The gene discussed is EPHA2; the disease is neoplasm.